Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Quality of Life Related to the Care of Women Living With HIV During the Perinatal Period

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

"The improvement of patient care by assessing the Quality of Life Related to Care (QLRC) in pregnant women living with HIV is of great importance for informing decision-making, resource allocation, and health policy formulation Prospective descriptive survey of women living with HIV followed for a pregnancy in the Infectious diseases department of Bichat-Claude Bernard Hospital, PARIS, France, between the first obstetric ultrasound and the 28th week of amenorrhea. After recruitment during a follow-up consultation: Information regarding the prenatal and perinatal management of HIV and the infant's outcomes up to 12 months will be collected retrospectively through the medical records. Three self-questionnaires, either completed independently or with assistance, will be administered at inclusion (between the first obstetric ultrasound and 28 weeks of amenorrhea), during the third trimester of pregnancy, and at 1 year postpartum."

Who May Be Eligible (Plain English)

"Inclusion Criteria - Woman living with HIV - Age ≥ 18 years - Pregnant - due date between the first obstetric ultrasound and 28 weeks of amenorrhea - Information provided about the study and the right to refuse participation Exclusion Criteria - Refusal to participate in the study - Non-French speaker" Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
"Inclusion Criteria * Woman living with HIV * Age ≥ 18 years * Pregnant - due date between the first obstetric ultrasound and 28 weeks of amenorrhea * Information provided about the study and the right to refuse participation Exclusion Criteria * Refusal to participate in the study * Non-French speaker"

Treatments Being Tested

OTHER

Questionary

Three self-questionnaires, either completed independently or with assistance, will be administered at inclusion (between the first obstetric ultrasound and 28 weeks of amenorrhea), during the third trimester of pregnancy, and at 1 year postpartum

Locations (1)

Hôpital Bichat-Claude Bernard
Paris, France